These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12188324)

  • 1. Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weights.
    Roberts TP; Turetschek K; Preda A; Novikov V; Moeglich M; Shames DM; Brasch RC; Weinmann HJ
    Acad Radiol; 2002 Aug; 9 Suppl 2():S511-3. PubMed ID: 12188324
    [No Abstract]   [Full Text] [Related]  

  • 2. MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model.
    Turetschek K; Preda A; Floyd E; Shames DM; Novikov V; Roberts TP; Wood JM; Fu Y; Carter WO; Brasch RC
    Acad Radiol; 2002 Aug; 9 Suppl 2():S519-20. PubMed ID: 12188326
    [No Abstract]   [Full Text] [Related]  

  • 3. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
    de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
    Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
    Olaso E; Vidal-Vanaclocha F
    Methods Mol Med; 2003; 85():79-86. PubMed ID: 12710199
    [No Abstract]   [Full Text] [Related]  

  • 5. Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?
    Brasch RC; Gossmann A; Helbich TH; Kuriyama N; Roberts TP; Shames DM; van Bruggen N; Wendland MF; Israel MA
    Acad Radiol; 2002 Aug; 9 Suppl 2():S326-7. PubMed ID: 12188263
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamic MRI enhanced with albumin-(Gd-DTPA)30 or ultrasmall superparamagnetic iron oxide particles (NC100150 injection) for the measurement of microvessel permeability in experimental breast tumors.
    Turetschek K; Huber S; Helbich T; Floyd E; Tarlo KS; Roberts TP; Shames DM; Wendland MF; Brasch RC
    Acad Radiol; 2002 May; 9 Suppl 1():S112-4. PubMed ID: 12019843
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing perfusion and capillary permeability changes induced by a VEGF inhibitor in human tumor xenografts using macromolecular MR imaging contrast media.
    Clément O; Pradel C; Siauve N; Frouin F; Bruneteau G; Kahn E; Frija G; Cuénod CA
    Acad Radiol; 2002 Aug; 9 Suppl 2():S328-9. PubMed ID: 12188264
    [No Abstract]   [Full Text] [Related]  

  • 8. High resolution MRI of MCF7 human breast tumors: complemented use of iron oxide microspheres and Gd-DTPA.
    Furman-Haran E; Margalit R; Grobgeld D; Degani H
    J Magn Reson Imaging; 1998; 8(3):634-41. PubMed ID: 9626879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tipping the balance for angiogenic disorders.
    Gao G; Ma J
    Drug Discov Today; 2002 Feb; 7(3):171-2. PubMed ID: 11815230
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRI.
    Leenders W; Küsters B; Pikkemaat J; Wesseling P; Ruiter D; Heerschap A; Barentsz J; de Waal RM
    Int J Cancer; 2003 Jul; 105(4):437-43. PubMed ID: 12712432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment.
    Claes A; Gambarota G; Hamans B; van Tellingen O; Wesseling P; Maass C; Heerschap A; Leenders W
    Int J Cancer; 2008 May; 122(9):1981-6. PubMed ID: 18081012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between gadopentetate and feruglose (Clariscan)-enhanced MR-mammography: preliminary clinical experience.
    Daldrup-Link HE; Kaiser A; Link TM; Settles M; Helbich T; Werner M; Roberts TP; Rummeny EJ
    Acad Radiol; 2002 Aug; 9 Suppl 2():S343-7. PubMed ID: 12188270
    [No Abstract]   [Full Text] [Related]  

  • 13. Basic physics of MR contrast agents and maximization of image contrast.
    Hendrick RE; Haacke EM
    J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.
    Abdollahi A; Lipson KE; Han X; Krempien R; Trinh T; Weber KJ; Hahnfeldt P; Hlatky L; Debus J; Howlett AR; Huber PE
    Cancer Res; 2003 Jul; 63(13):3755-63. PubMed ID: 12839971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent.
    Karczmar GS; Fan X; Al-Hallaq H; River JN; Tarlo K; Kellar KE; Zamora M; Rinker-Schaeffer C; Lipton MJ
    Acad Radiol; 2002 May; 9 Suppl 1():S115-8. PubMed ID: 12019844
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
    Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
    Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential value of iron oxide nanoparticles in brain tumor treatment.
    Gutin PH
    AJNR Am J Neuroradiol; 2002 Apr; 23(4):505. PubMed ID: 11950633
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative assessment of the contrast behavior of typical focal hepatic lesions before and after the administration of Gd-DTPA and superparamagnetic iron oxide particles.
    Helmberger T; Holzknecht N; Reiser M
    Acad Radiol; 2002 Aug; 9 Suppl 2():S468-72. PubMed ID: 12188311
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI.
    Gambarota G; Leenders W; Maass C; Wesseling P; van der Kogel B; van Tellingen O; Heerschap A
    Br J Cancer; 2008 Jun; 98(11):1784-9. PubMed ID: 18506183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.